Using murine corticotrope tumor cells, van der Hoek et al. demonstrated a dexamethasone-dependent inhibitory effect of octreotide treatment targeting SST2 that was not found with analogs that targeted primarily SST5 [15]. This evidence concerns the gene SSTR5 and neoplasm.